![Faraz Ali](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Faraz Ali
Algemeen Directeur bij
TENAYA THERAPEUTICS, INC.
Vermogen: 371 370 $ op 31-08-2026
Profiel
Faraz Ali is President, Chief Executive Officer & Director at Tenaya Therapeutics, Inc. since 2026 and has been with the company since 2018.
Mr. Ali is also Director at Alliance for Regenerative Medicine since 2023.
Former roles include Head-U.S.
Marketing & Strategic Planning at Genzyme Corp.
from 2001 to 2010, Chief Business Officer at REGENXBIO, Inc. from 2016 to 2018, and Vice President-Global Commercial Development at Genetix Biotherapeutics, Inc. from 2011 to 2016.
Education includes undergraduate studies at Stanford University and an MBA from Harvard Business School.
Bekende belangen in openbare bedrijven
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
| 10-09-2026 | 539.782 ( 0,24% ) | 371 370 $ | 31-08-2026 |
Actieve functies van Faraz Ali
| Bedrijven | Functie | Begin |
|---|---|---|
| TENAYA THERAPEUTICS, INC. | Algemeen Directeur | 01-06-2018 |
Alliance for Regenerative Medicine
 Alliance for Regenerative Medicine Medical/Nursing ServicesHealth Services Promotes legislative, regulatory and reimbursement initiatives for regenerative medicine | Directeur/Bestuurslid | 01-01-2023 |
Eerdere bekende functies van Faraz Ali
| Bedrijven | Functie | Einde |
|---|---|---|
| REGENXBIO INC. | Corporate Officer/Principal | 05-01-2018 |
| GENETIX BIOTHERAPEUTICS, INC. | Corporate Officer/Principal | 01-02-2016 |
Genzyme Corp.
 Genzyme Corp. Pharmaceuticals: MajorHealth Technology Develops and manufactures therapies for rare diseases, multiple sclerosis, immunology & oncology | Corporate Officer/Principal | 01-11-2010 |
Opleiding van Faraz Ali
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
68
Eerstegraads connecties
7
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 7 |
|---|---|
Genzyme Corp.
Genzyme Corp. Pharmaceuticals: MajorHealth Technology Develops and manufactures therapies for rare diseases, multiple sclerosis, immunology & oncology | Health Technology |
REGENXBIO, Inc.
 REGENXBIO, Inc. Pharmaceuticals: MajorHealth Technology Develops gene therapy | Health Technology |
Stanford University
 Stanford University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
bluebird bio, Inc.
 bluebird bio, Inc. BiotechnologyHealth Technology Develops genetic therapies based on blood stem cells | Health Technology |
Alliance for Regenerative Medicine
Alliance for Regenerative Medicine Medical/Nursing ServicesHealth Services Promotes legislative, regulatory and reimbursement initiatives for regenerative medicine | Health Services |
Harvard Business School
 Harvard Business School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Tenaya Therapeutics, Inc.
 Tenaya Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops therapeutics for heart failure | Health Technology |
